FDA Disputes Deramiocel Efficacy; HIV Funding Hits 20-Year Low

References

1. 1.Silverman, E. (2026, July 28). Pharmalittle: We're reading about FDA views on a Duchenne drug, GSK cost savings, and more. STAT News. https://www.statnews.com/pharmalot/2026/07/28/fda-duchenne-drug-gsk-cost-savings-plan/
2. 2.UNAIDS. (2026). Global HIV & AIDS statistics — Financing report 2026. Joint United Nations Programme on HIV/AIDS. https://www.unaids.org/en/resources/documents/2026
3. 3.Duan, D., Goemans, N., Takeda, S., Mercuri, E., & Aartsma-Rus, A. (2021). Duchenne muscular dystrophy. Nature Reviews Disease Primers, 7(1), 13. https://doi.org/10.1038/s41572-021-00248-3
4. 4.Capricor Therapeutics. (2025). Capricor Therapeutics announces positive Phase 3 results for deramiocel in Duchenne muscular dystrophy [Press release]. Capricor Therapeutics Investor Relations. https://www.capricor.com
5. 5.Bekker, L. G., Alleyne, G., Baral, S., Cepeda, J., Daskalakis, D., Dowdy, D., Dybul, M., Eholie, S., Esom, K., Garnett, G., Grimsrud, A., Hakim, J., Havlir, D., Isbell, M. T., Johnson, L., Kamarulzaman, A., Kasaie, P., Kazatchkine, M., & Kilonzo, N. (2018). Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals. The Lancet, 392(10144), 312–358. https://doi.org/10.1016/S0140-6736(18)31070-5
6. 6.Australian Government Department of Health and Aged Care. (2023). Eighth National HIV Strategy 2023–2030. Australian Government. https://www.health.gov.au/resources/publications/eighth-national-hiv-strategy-2023-2030
7. 7.Kesselheim, A. S., & Avorn, J. (2022). Accelerated approval of cancer drugs — weighing the trade-offs. New England Journal of Medicine, 386(18), 1677–1680. https://doi.org/10.1056/NEJMp2201045
8. 8.Kates, J., Wexler, A., & Lief, E. (2025). Financing the response to HIV in low- and middle-income countries: International assistance from donor governments. Kaiser Family Foundation / UNAIDS. https://www.kff.org/global-health-policy/report/financing-the-response-to-hiv-in-low-and-middle-income-countries-international-assistance-from-donor-governments/